LadRx Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LADX research report →
Companywww.cytrx.com
LadRx Corporation, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat patients with cancer. The company's advanced drug conjugate, aldoxorubicin that is in late-stage clinical trials is a version of anti-cancer drug doxorubicin. Its pre-clinical therapeutics comprise linker activated drug releases 7, 8, 9, and 10 targeted against cancer The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022.
- CEO
- John Y. Caloz
- IPO
- 1989
- Employees
- 2
- HQ
- Los Angeles, CA, US
Price Chart
Valuation
- Market Cap
- $24.75K
- P/E
- -0.06
- P/S
- 3.58
- P/B
- -0.01
- EV/EBITDA
- 0.13
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 40.77%
- Op Margin
- -20061.01%
- Net Margin
- -5607.96%
- ROE
- 21.84%
- ROIC
- 65.05%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-1,589,685,000 · -397081.59%
- EPS
- $-3210.89 · -472289.71%
- Op Income
- $-3,623,142
- FCF YoY
- -129337.93%
Performance & Tape
- 52W High
- $2.40
- 52W Low
- $0.01
- 50D MA
- $0.08
- 200D MA
- $0.90
- Beta
- 1.56
- Avg Volume
- 113
Get TickerSpark's AI analysis on LADX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 15, 24 | Caldwell Joel K | other | 5,000 |
| Jan 15, 24 | Claiborne Cary J | other | 5,000 |
| Jan 15, 24 | Simpson Jennifer K. | other | 5,000 |
| Jan 15, 24 | CALOZ JOHN Y | other | 15,000 |
| Jan 15, 24 | Snowdy Stephen | other | 25,000 |
Our LADX Coverage
We haven't published any research on LADX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LADX Report →